Accelerating the Surgical Timeline
Following orthopedic or general surgery, the body initiates a massive inflammatory response followed by a long remodeling phase. Biohackers and athletes have increasingly turned to specific peptides to compress this timeline, attempting to cut recovery times by 30-50%.
The primary goal immediately post-op is modulating (not eliminating) inflammation and drastically increasing collagen synthesis at the incision and internal repair sites.
Phase 1: Acute Inflammation Management
Immediately post-surgery, BPC-157 is deployed. Because BPC-157 accelerates angiogenesis (new blood vessel formation), it vastly increases nutrient delivery to the hypoxic surgical site. It also modulates the inflammatory cascade, reducing acute swelling and pain.
Warning: Never use BPC-157 (or any angiogenic compound) if the surgery involves tumor removal, as angiogenesis can promote cancer growth.
Phase 2: Tissue Remodeling
As the acute phase passes (days 7+), TB-500 (Thymosin Beta-4) is introduced. TB-500 prevents the formation of excessive internal scar tissue (fibrosis) by regulating actin. This ensures the newly formed tissue is flexible and functional, rather than rigid and prone to re-injury.
GHK-Cu (Copper Peptide) is also frequently used to accelerate skin closure, reduce surface scarring, and radically boost Type I collagen production.

Clinical Caution
Using experimental peptides immediately post-surgery carries extreme risks regarding infection, unregulated cell growth, and interactions with prescribed antibiotics and analgesics. This is highly experimental pharmacology.